Peerless Technology Group PLC
22 December 2003
For immediate release
22 December 2003
Peerless Technology Group plc (to be re-named Alliance Pharma PLC)
('Peerless' or the 'Company')
Result of EGM
The Board of Peerless is pleased to announce that at the extraordinary general
meeting held earlier today, all of the resolutions proposed in the Notice of
EGM, details of which were set out in the circular to Peerless shareholders
dated 28 November 2003 (the 'Circular'), were duly passed. The resolutions were
in relation to, inter alia, the Acquisition of the whole of the issue share
capital of Alliance Pharmaceuticals Ltd ('Alliance'), the Placings (excluding
the Vendor Placing) and Open Offer of 22,914,736 New Ordinary Shares and £7.5m
8% Convertible Loan Stock in the capital of the Company and the change of the
Company's name to Alliance Pharma PLC.
Application has been made to the London Stock Exchange for the Enlarged Share
Capital of 110,793,903 Ordinary Shares and for the £7.5 million, 8 per cent.
Convertible Loan Stock to be admitted to trading on AIM. It is expected that
Admission will become effective and that dealings in the Ordinary Shares and the
convertible Loan Stock will commence on 23 December 2003.
The acquisition of Alliance has been completed subject only to such Admission
taking place. With effect from Admission, Mr Ajaz Ahmed, Mr Jeremy Fenn and Mr
Richard James have resigned as Directors of the company and the following have
been appointed as Directors of the Company:
John Dawson (Chief Executive)
Anthony Richard Booley (Sales and Marketing Director)
Stella Anne Dawson (aka Sam Madden) (Technical and Regulatory Director)
Madelein Elizabeth Scott (Finance Director and Company Secretary)
Paul Ranson (Non-Executive Director)
Mr Steve Harris, who is already a Director of the Company, remains a
non-executive director.
Unless the context otherwise requires, capitalised terms used in this
announcement shall have the meanings given to them in the Circular.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.